全膝关节置换术后翻修的终生风险:新西兰关节登记研究
基于新西兰关节登记数据库1999年1月至2016年12月18年间所有初次全膝关节置换术数据,按年龄、性别和ASA分级计算翻修终生风险。总体十年生存率为95.6%,46至50岁组翻修终生风险为22.4%,随年龄增加线性下降至90至95岁组的1.15%;46至50岁年轻男性终生风险最高(25.2%)。作者认为翻修终生风险可能比特定时间点的假体生存率对患者咨询更有意义。
要点
- 总体十年生存率为95.6%,在46至50岁组最低,随年龄增加而升高。
- 翻修终生风险在46至50岁组为22.4%,随年龄增加线性下降至90至95岁组的1.15%。
- 所有年龄组中较高的ASA分级与翻修终生风险增加相关;46至50岁年轻男性终生风险最高(25.2%)。
核心结论
- 翻修终生风险可能比特定时间点的假体生存率在术前咨询时是更有意义的结果衡量指标。
- 本研究凸显年轻男性患者因所有指征(包括感染)行翻修手术的终生风险相当高。
研究设计与样本
- 使用新西兰关节登记数据库,获取1999年1月至2016年12月18年间所有初次全膝关节置换术的翻修率、死亡率和翻修指征。
- 按初次全膝关节置换术时年龄分组,并根据年龄、性别和美国麻醉医师协会(ASA)分级计算翻修终生风险,同时分析各年龄组最常见的翻修指征。
主要发现
- 总体十年生存率为95.6%,在46至50岁组最低,并随年龄增加依次升高。
- 初次手术时46至50岁组翻修终生风险为22.4%,随年龄增加线性下降至90至95岁组的1.15%。
- 所有年龄组中较高的ASA分级与翻修终生风险增加相关。
- 最常见的三个翻修指征为无菌性松动、感染和不明原因疼痛。
- 46至50岁年轻男性翻修终生风险最高(25.2%)。
关键数值与推荐
- 总体十年生存率为95.6%。
- 46至50岁组翻修终生风险为22.4%,90至95岁组为1.15%。
- 46至50岁年轻男性翻修终生风险最高,为25.2%。
临床怎么用
- 作者认为翻修终生风险可能比特定时间点的假体生存率在术前咨询时是更有意义的结果衡量指标。
- 本研究凸显年轻男性患者因所有指征(包括感染)行翻修手术的终生风险相当高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The success of total knee arthroplasty (TKA) is usually measured using functional outcome scores and revision-free survivorship. However, reporting the lifetime risk of revision may be more meaningful to patients when gauging risks, especially in younger patients. We aimed to assess the lifetime risk of revision for patients in different age categories at the time of undergoing primary TKA. METHODS: The New Zealand Joint Registry database was used to obtain revision rates, mortality, and the indications for revision for all primary TKAs performed during an 18-year period between January 1999 and December 2016. Patients were stratified into age groups at the time of the initial TKA, and the lifetime risk of revision was calculated according to age, sex, and the American Society of Anesthesiologists (ASA) grade. The most common indications for revision were also analyzed for each age group. RESULTS: The overall ten-year survival rate was 95.6%. This was lowest in the youngest age group (between 46 and 50 years) and increased sequentially with increasing age. The lifetime risk of requiring revision was 22.4% in those aged between 46 and 50 years at the time of the initial surgery, and decreased linearly with increasing age to 1.15% in those aged between 90 and 95 years at the time of surgery. Higher ASA grades were associated with increased lifetime risk of revision in all age groups. The three commonest indications for revision were aseptic loosening, infection, and unexplained pain. Young males, aged between 46 and 50 years, had the highest lifetime risk of revision (25.2%). CONCLUSION: Lifetime risk of revision may be a more meaningful measure of outcome than implant survival at defined time periods when counselling patients prior to TKA. This study highlights the considerably higher lifetime risk of revision surgery for all indications, including infection, in younger male patients. Cite this article: Bone Joint J 2022;104-B(2):235-241.
引用
- Stone B, Nugent M, Young SW, et al. The lifetime risk of revision following total knee arthroplasty : a New Zealand Joint Registry study. Bone Joint J. 2022. PMID: 35094573. doi:10.1302/0301-620X.104B2.BJJ-2021-0890.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。